These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 8058744

  • 21. C-Terminal HIV-1 Transframe p6* Tetrapeptide Blocks Enhanced Gag Cleavage Incurred by Leucine Zipper Replacement of a Deleted p6* Domain.
    Yu FH, Huang KJ, Wang CT.
    J Virol; 2017 May 15; 91(10):. PubMed ID: 28250114
    [Abstract] [Full Text] [Related]

  • 22. In vitro refolding of cyclomaltodextrin glucanotransferase from cytoplasmic inclusion bodies formed upon expression in Escherichia coli.
    Hellman J, Lassila P, Mäntsälä P.
    Protein Expr Purif; 1995 Feb 15; 6(1):56-62. PubMed ID: 7756839
    [Abstract] [Full Text] [Related]

  • 23. A Functional Interplay between Human Immunodeficiency Virus Type 1 Protease Residues 77 and 93 Involved in Differential Regulation of Precursor Autoprocessing and Mature Protease Activity.
    Counts CJ, Ho PS, Donlin MJ, Tavis JE, Chen C.
    PLoS One; 2015 Feb 15; 10(4):e0123561. PubMed ID: 25893662
    [Abstract] [Full Text] [Related]

  • 24. Mutations in the protease gene of human immunodeficiency virus type 1 affect release and stability of virus particles.
    Park J, Morrow CD.
    Virology; 1993 Jun 15; 194(2):843-50. PubMed ID: 8503189
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Proteolytic activity in vivo and encapsidation of recombinant human immunodeficiency virus type 1 proteinase expressed in baculovirus-infected cells.
    Royer M, Bardy M, Gay B, Tournier J, Boulanger P.
    J Gen Virol; 1997 Jan 15; 78 ( Pt 1)():131-42. PubMed ID: 9010296
    [Abstract] [Full Text] [Related]

  • 28. Visualizing transient events in amino-terminal autoprocessing of HIV-1 protease.
    Tang C, Louis JM, Aniana A, Suh JY, Clore GM.
    Nature; 2008 Oct 02; 455(7213):693-6. PubMed ID: 18833280
    [Abstract] [Full Text] [Related]

  • 29. Overexpression of bacterio-opsin in Escherichia coli as a water-soluble fusion to maltose binding protein: efficient regeneration of the fusion protein and selective cleavage with trypsin.
    Chen GQ, Gouaux JE.
    Protein Sci; 1996 Mar 02; 5(3):456-67. PubMed ID: 8868482
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Terminal interface conformations modulate dimer stability prior to amino terminal autoprocessing of HIV-1 protease.
    Agniswamy J, Sayer JM, Weber IT, Louis JM.
    Biochemistry; 2012 Feb 07; 51(5):1041-50. PubMed ID: 22242794
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Natural variation in HIV-1 protease, Gag p7 and p6, and protease cleavage sites within gag/pol polyproteins: amino acid substitutions in the absence of protease inhibitors in mothers and children infected by human immunodeficiency virus type 1.
    Barrie KA, Perez EE, Lamers SL, Farmerie WG, Dunn BM, Sleasman JW, Goodenow MM.
    Virology; 1996 May 15; 219(2):407-16. PubMed ID: 8638406
    [Abstract] [Full Text] [Related]

  • 34. Expression of recombinant human phenylalanine hydroxylase as fusion protein in Escherichia coli circumvents proteolytic degradation by host cell proteases. Isolation and characterization of the wild-type enzyme.
    Martinez A, Knappskog PM, Olafsdottir S, Døskeland AP, Eiken HG, Svebak RM, Bozzini M, Apold J, Flatmark T.
    Biochem J; 1995 Mar 01; 306 ( Pt 2)(Pt 2):589-97. PubMed ID: 7887915
    [Abstract] [Full Text] [Related]

  • 35. Hydrophilic peptides derived from the transframe region of Gag-Pol inhibit the HIV-1 protease.
    Louis JM, Dyda F, Nashed NT, Kimmel AR, Davies DR.
    Biochemistry; 1998 Feb 24; 37(8):2105-10. PubMed ID: 9485357
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Expression and characterization of human foamy virus proteinase.
    Fenyöfalvi G, Bagossi P, Copeland TD, Oroszlan S, Boross P, Tözsér J.
    FEBS Lett; 1999 Dec 03; 462(3):397-401. PubMed ID: 10622733
    [Abstract] [Full Text] [Related]

  • 38. Processing sites in the human immunodeficiency virus type 1 (HIV-1) Gag-Pro-Pol precursor are cleaved by the viral protease at different rates.
    Pettit SC, Lindquist JN, Kaplan AH, Swanstrom R.
    Retrovirology; 2005 Nov 01; 2():66. PubMed ID: 16262906
    [Abstract] [Full Text] [Related]

  • 39. HIV-1 protease with leucine zipper fused at N-terminus exhibits enhanced linker amino acid-dependent activity.
    Yu FH, Wang CT.
    Retrovirology; 2018 Apr 14; 15(1):32. PubMed ID: 29655366
    [Abstract] [Full Text] [Related]

  • 40. Identification of a topology control domain in the tetracycline resistance protein.
    Miller KW, Jewell JE.
    Arch Biochem Biophys; 1995 Oct 01; 322(2):445-52. PubMed ID: 7574720
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.